chr18-12340220-G-T
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM1PM2PM5PP2PP3_Strong
The NM_006796.3(AFG3L2):c.1961C>A(p.Thr654Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T654I) has been classified as Likely pathogenic.
Frequency
Consequence
NM_006796.3 missense
Scores
Clinical Significance
Conservation
Publications
- facial palsy, congenital, with ptosis and velopharyngeal dysfunctionInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006796.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| AFG3L2 | NM_006796.3 | MANE Select | c.1961C>A | p.Thr654Asn | missense | Exon 15 of 17 | NP_006787.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| AFG3L2 | ENST00000269143.8 | TSL:1 MANE Select | c.1961C>A | p.Thr654Asn | missense | Exon 15 of 17 | ENSP00000269143.2 | ||
| AFG3L2 | ENST00000691179.1 | c.1886C>A | p.Thr629Asn | missense | Exon 14 of 16 | ENSP00000509010.1 | |||
| AFG3L2 | ENST00000688199.1 | c.1823C>A | p.Thr608Asn | missense | Exon 14 of 16 | ENSP00000510237.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Uncertain:1
Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt AFG3L2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces threonine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 654 of the AFG3L2 protein (p.Thr654Asn). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with AFG3L2-related conditions.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at